SCHEMBL1827753

SCHEMBL1827753

NC(=O)C(OCc1ccccc1)c1ccccc1OS(=O)(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
ALDH1A1 P00352 5/20 0.40
SLC1A3 P43003 2/20 0.39
SLC1A2 P43004 2/20 0.39
SLC1A1 P43005 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
PKM P14618 1/20 0.37
CA1 P00915 4/20 0.37
CA2 P00918 4/20 0.37
ACHE P22303 1/20 0.37
HTT P42858 3/20 0.36
LMNA P02545 3/20 0.36
KDM4E B2RXH2 1/20 0.36
METAP2 P50579 1/20 0.36
METAP1 P53582 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1823526 0.88 MAPT (0.41) MAPTALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL1823275 0.85 CA1 (0.45) MAPTALDH1A1MEN1KMT2ACA1
SCHEMBL1825213 0.82 LMNA (0.46) MAPTALDH1A1MEN1KMT2ACYP1A2
SCHEMBL1828067 0.82 ALDH1A1 (0.45) MAPTALDH1A1MEN1KMT2APKM
SCHEMBL1826711 0.81 LMNA (0.44) MAPTALDH1A1MEN1KMT2ACYP1A2
SCHEMBL1827749 0.80 TDP1 (0.44) MAPTALDH1A1SLC1A3SLC1A2SLC1A1
SCHEMBL1827722 0.80 ALDH1A1 (0.43) MAPTALDH1A1MEN1KMT2APKM
SCHEMBL3571677 0.79 LMNA (0.44) MAPTALDH1A1MEN1KMT2ACYP1A2
SCHEMBL1825970 0.79 ALDH1A1 (0.43) MAPTALDH1A1MEN1KMT2ACYP1A2
SCHEMBL1825638 0.79 MAPT (0.42) MAPTALDH1A1MEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 MAPT 4712/4885ALDH1A1 1099/4885SLC1A3 1833/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 MAPT 2237/4885ALDH1A1 1440/4885SLC1A3 3927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.